Suppr超能文献

慢性病毒性肝炎患者谷氨酰胺和硝基酪氨酸的血液水平

Blood Levels of Glutamine and Nitrotyrosine in Patients with Chronic Viral Hepatitis.

作者信息

Murad Hussam, Tayeb Haythum, Mosli Mahmoud, Rafeeq Misbahuddin, Basheikh Mohammed

机构信息

Department of Pharmacology, Faculty of Medicine, Rabigh, King Abdulaziz University, Jeddah, Saudi Arabia.

Department of Pharmacology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

Int J Gen Med. 2021 Nov 24;14:8753-8762. doi: 10.2147/IJGM.S337909. eCollection 2021.

Abstract

PURPOSE

Oxidative stress is involved in pathogenesis of chronic viral hepatitis. Glutamine is an antioxidant, but there is a controversy about its risk-benefits. Nitrotyrosine is an oxidative stress marker. This observational cross-sectional study was designed to compare blood levels of glutamine and nitrotyrosine in treated untreated chronic viral hepatitis patients.

PATIENTS AND METHODS

Five groups (n = 250) were included: hepatitis B untreated (HBV), hepatitis C untreated (HCV), HBV treated (HBVT), and HCV treated (HCVT) groups plus a normal control group. Liver function tests and blood levels of glutamine, nitrotyrosine, viral loads, and HBsAg were measured.

RESULTS

Blood levels of glutamine and nitrotyrosine in all patient groups significantly increased compared with normal controls with non-significant differences in-between. Both tests showed significant large correlations with HBV-DNA or HCV-RNA test positivity, high accuracies, and cutoff scores with high sensitivities and specificities. The viral loads and HBsAg levels were significantly lower in treated untreated groups. However, they poorly correlated with levels of glutamine and nitrotyrosine in all patient groups.

CONCLUSION

Blood levels of glutamine and nitrotyrosine significantly increased in treated and untreated chronic viral hepatitis B and C patients compared with normal controls. Both tests showed high accuracies and cutoff scores with high sensitivities and specificities. However, they did not differ significantly in treated untreated patients. To our knowledge, this is the first data showing elevation of glutamine and nitrotyrosine in treated and untreated chronic viral hepatitis. A prospective longitudinal study with repeated measurements of glutamine and nitrotyrosine is recommended to verify if they can predict response to treatment. Study of other oxidative stress markers is also advised to clarify if the elevated nitrotyrosine could be an oxidative stress marker in these patients, and whether the increased glutamine could act as an antioxidant or as a predictive agent for deleterious consequences.

摘要

目的

氧化应激参与慢性病毒性肝炎的发病机制。谷氨酰胺是一种抗氧化剂,但其风险效益存在争议。硝基酪氨酸是一种氧化应激标志物。本观察性横断面研究旨在比较经治疗和未经治疗的慢性病毒性肝炎患者的谷氨酰胺和硝基酪氨酸血水平。

患者与方法

纳入五组(n = 250):未经治疗的乙型肝炎(HBV)组、未经治疗的丙型肝炎(HCV)组、经治疗的HBV(HBVT)组、经治疗的HCV(HCVT)组以及一个正常对照组。检测肝功能、谷氨酰胺、硝基酪氨酸血水平、病毒载量和HBsAg。

结果

与正常对照组相比,所有患者组的谷氨酰胺和硝基酪氨酸血水平均显著升高,组间差异无统计学意义。两项检测均与HBV-DNA或HCV-RNA检测阳性呈显著高度相关,具有高准确性、临界值分数以及高灵敏度和特异性。经治疗组和未经治疗组的病毒载量和HBsAg水平均显著降低。然而,它们与所有患者组的谷氨酰胺和硝基酪氨酸水平相关性较差。

结论

与正常对照组相比,经治疗和未经治疗的慢性乙型和丙型病毒性肝炎患者的谷氨酰胺和硝基酪氨酸血水平均显著升高。两项检测均具有高准确性、临界值分数以及高灵敏度和特异性。然而,经治疗组和未经治疗组之间差异无统计学意义。据我们所知,这是首份显示经治疗和未经治疗的慢性病毒性肝炎中谷氨酰胺和硝基酪氨酸升高的数据。建议进行一项前瞻性纵向研究,重复测量谷氨酰胺和硝基酪氨酸,以验证它们是否能够预测治疗反应。还建议研究其他氧化应激标志物,以阐明升高的硝基酪氨酸是否可能是这些患者的氧化应激标志物,以及增加的谷氨酰胺是否可作为抗氧化剂或有害后果的预测因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a553/8631182/face2aa96d2c/IJGM-14-8753-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验